Company “OAD-27,” as part of its distribution activities, provides our partners with unique services for introducing a drug to the market, promoting it, storing it, and transporting it to ensure the rapid delivery of therapy to patients. The full cycle of introducing medicinal products and drugs for the treatment of rare and orphan diseases to the market includes a project-based approach to defining market needs and developing a unique strategy to achieve maximum results. Each project for the introduction of medicinal products starts with market assessment and identification of key players in a specific therapeutic area. The need for new therapies and key physicians in the nosology who are capable of shaping the medical community’s opinion on innovations in disease treatment is determined. We then provide services for organizing genetic testing of potential candidates at the local level or sending biomaterial to selected laboratories outside the Republic of Kazakhstan to identify results and approve candidates for therapy. Additionally, we provide services for selecting the best channel for procuring the medicinal product, submitting documentation for inclusion of the drug in the necessary procurement lists, and registering the drug in the market of the Republic of Kazakhstan. For some of our partners, we offer joint promotion services, which include coverage of regions in Kazakhstan to increase the product’s recognition, organization of round tables, and preparation of presentations for the medical community. The company employs three medical representatives to cover the Republic of Kazakhstan. For companies that have their own representation in the Republic of Kazakhstan or need an additional channel to promote their products, we offer joint promotion services with shared responsibilities. In this case, we cover selected areas for promoting the drug, which significantly helps to reduce representation costs, saving time and resources.